Literature DB >> 17703463

Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.

Valentina De Grandis1, Anna Rita Bizzarri, Salvatore Cannistraro.   

Abstract

Molecular interaction between p53 tumor suppressor and the copper protein azurin (AZ) has been demonstrated to enhance p53 stability and hence antitumoral function, opening new perspectives in cancer treatment. While some experimental work has provided evidence for AZ binding to p53, no crystal structure for the p53-AZ complex was solved thus far. In this work the association between AZ and the p53 DNA-binding domain (DBD) was investigated by computational methods. Using a combination of rigid-body protein docking, experimental mutagenesis information, and cluster analysis 10 main p53 DBD-AZ binding modes were generated. The resulting structures were further characterized by molecular dynamics (MD) simulations and free energy calculations. We found that the highest scored docking conformation for the p53 DBD-AZ complex also yielded the most favorable free energy value. This best three-dimensional model for the complex was validated by using a computational mutagenesis strategy. In this structure AZ binds to the flexible L(1) and s(7)-s(8) loops of the p53 DBD and stabilizes them through protein-protein tight packing interactions, resulting in high degree of both surface matching and electrostatic complementarity. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703463     DOI: 10.1002/jmr.840

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  14 in total

1.  Molecular simulation of protein-surface interactions: benefits, problems, solutions, and future directions.

Authors:  Robert A Latour
Journal:  Biointerphases       Date:  2008-09       Impact factor: 2.456

Review 2.  Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.

Authors:  Meng Gao; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  Protein Sci       Date:  2017-10-27       Impact factor: 6.725

Review 3.  Microbial-based therapy of cancer: current progress and future prospects.

Authors:  Nuno Bernardes; Raquel Seruca; Ananda M Chakrabarty; Arsenio M Fialho
Journal:  Bioeng Bugs       Date:  2009-12-02

Review 4.  Anticancer Actions of Azurin and Its Derived Peptide p28.

Authors:  Fan Huang; Qianhui Shu; Zhaojie Qin; Jianglin Tian; Zhengding Su; Yongqi Huang; Meng Gao
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

5.  SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor.

Authors:  Fabio Domenici; Anna Rita Bizzarri; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2011-09-19

6.  Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.

Authors:  Anna Rita Bizzarri; Simona Santini; Emilia Coppari; Monica Bucciantini; Silvia Di Agostino; Tohru Yamada; Craig W Beattie; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2011-11-24

7.  Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53.

Authors:  Chuong Nguyen; Van Duy Nguyen
Journal:  Biomed Res Int       Date:  2016-04-30       Impact factor: 3.411

Review 8.  Molecular dynamic simulation insights into the normal state and restoration of p53 function.

Authors:  Ting Fu; Hanyi Min; Yong Xu; Jianzhong Chen; Guohui Li
Journal:  Int J Mol Sci       Date:  2012-08-03       Impact factor: 6.208

9.  p28, a first in class peptide inhibitor of cop1 binding to p53.

Authors:  T Yamada; K Christov; A Shilkaitis; L Bratescu; A Green; S Santini; A R Bizzarri; S Cannistraro; T K D Gupta; C W Beattie
Journal:  Br J Cancer       Date:  2013-06-04       Impact factor: 7.640

10.  A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins.

Authors:  Emilia Coppari; Tohru Yamada; Anna Rita Bizzarri; Craig W Beattie; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.